Rapid Evaluation for Pulmonary Embolism (PE)
or Deep Vein Thrombosis (DVT)
Deep vein thrombosis (DVT) and pulmonary embolism (PE), forms of venous thromboembolism (VTE), can result in significant morbidity and mortality if not treated. An accurate diagnosis is essential given the risks associated with anticoagulation therapy.
D-Dimer is one of the smallest fibrin degradation products arising directly from the body’s natural mechanism to break down blood clots. D-Dimer is produced in high amounts in the blood as plasmin breaks down blood clots, and is known for its unique cross-linked structure.
D-Dimer testing has been proposed as a non-invasive, inexpensive, rapid, and simple test in the evaluation of suspected VTE. D-dimer assays detect the presence of plasmin-mediated degradation products of fibrin. Levels increase following a thrombotic event with normalization within 15 to 20 days. Recent trauma or surgery, cancer, intravascular coagulation, serious infection, and other conditions can elevate D-dimer levels so D-dimer assays are typically sensitive but not specific.
Early diagnosis for VTE patients;
Assessment and evaluation of PE and DVT
Control Insert (PDF)
Assay Insert (PDF)
Point-of-Care Whole Blood D-Dimers Assay for VTE Exclusion in Emergency Patients, Tenon Hospital, Paris, France (abstract only, English, PDF)
mLabs D Dimer test is CE marked and distributed outside of the US.
To contact Micropoint to find out more or to purchase mLabs D-Dimer test, please email: firstname.lastname@example.org.